Costs of vision impairment: Present and future issues

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 7, Issue 5, 2007, Pages 523-527

  Keeffe, Jill E ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b VISION COOPERATIVE RESEARCH CENTRE   (Australia)

Author keywords

Blindness; Costs; Low vision; Methodology; Vision impairment

Indexed keywords

RANIBIZUMAB;

AUSTRALIA; CATARACT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISABLED PERSON; EYE CARE; GLAUCOMA; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH PROGRAM; HOSPITALIZATION COST; HUMAN; NON PROFIT ORGANIZATION; PRODUCTIVITY; QUALITY OF LIFE; REFRACTION ERROR; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; UNITED STATES; VISUAL IMPAIRMENT; VOCATIONAL EDUCATION; WORK DISABILITY;

EID: 36248939259     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.7.5.523     Document Type: Review

References (18)

1. Frick K, Foster A. The magnitude and cost of global blindness: an increasing problem that can be alleviated. Am. J. Ophthalmol. 135, 471-476 (2003).
2. World-Health Organization. Global Initiative for the Elimination of Avoidable Blindness. World Health Organization, Geneva, Switzerland (2000).
3. Resnikoff S, Pascolini D, Etya'ale D et al. Global data on visual impairment in the year 2002. Bull. World Health Organ. 82, 844-851 (2004).
4. Smith AF, Smith JG. The economic burden of global blindness: a price too high! Br. J. Ophthalmol. 80, 276-277 (1996).
5. Shomanna BR, Dandona L, Rao GN. Economic burden of blindness in India. Indian J. Ophthalmol. 46, 169-172 (1998).
6. Rein DB, Zhang P, Wirth KE et al. The economic burden of major adult visual disorders in the United States. Arch. Ophthalmol. 124, 1754-1760 (2006).
7. Keeffe JE, Chou SL, Lamoureux EL. Contribution of costs from lost productivity of carers to eye care costs. Presented at: 2007 ARVO Annual Meeting: The Aging Eye. Fort Lauderdale, FL, USA, 6-10 May 2007.
8. Taylor H, Pezzullo ML, Keeffe J. The economic impact and cost of visual impairment in Australia. Br. J. Ophthalmol. 90, 272-275 (2006).
9. Chou S-L, Lamoureux E, Keeffe J. Methods fbr measuring personal costs associated with vision impairment. Ophthalmic Epi. 13, 355-363 (2006).
10. Frick KD, Clark MA. A framework for comparing data collection methods for measuring costs and other outcomes that are aggregated over time. Ophthalmic Epi. 13, 351-354 (2006).
11. Taylor HR, Pezzullo ML, Nesbitt SJ, Keeffe JE. Costs of interventions for visual impairment. Am. J. Ophthalmol. 143, 561-565 (2007).
12. Frick KD, Gower EW, Kempen JH, Wolff JL. Economic impact of visual impairment and blindness in the United States. Arch. Ophthalmol. 125, 544-550 (2007).
13. The Economic Impact of Vision Problems. Prevent Blindness America, IL, USA (2007).
14. Hopley C, Carter R, Mitchell P. Measurement of the economic impact of visual impairment from age-related macular degeneration in Australian Clin. Exper. Ophthalmol. 31, 322-529 (2003).
15. Wight SE, Keeffe JE, Thies LS. Direct costs of blindness in Australia. Clin. Exper. Ophthalmol. 28, 140-142 (2000).
16. McCarty CA, Nanjan BM, Taylor HR. Vision impairment predicts 5 year mortality Br. J. Ophthalmol. 85, 322-326 (2001).
17. The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 122, 477-485 (2004).
18. Australian Health Ministers' Conference. National Framework for Action to Promote Eye Health and Prevent Avoidable Blindness and Vision Loss. Commonwealth of Australia, Canberra, Australia (2005).